These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 11217647

  • 1. [Diagnostic and clinical course features of lupus membranous glomerulonephritis].
    Domínguez-Gil B, Hernández E, Carreño A, González E, Ortiz M, Sierra MP, Rodicio JL, Praga M.
    Nefrologia; 2000; 20(6):523-31. PubMed ID: 11217647
    [Abstract] [Full Text] [Related]

  • 2. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D, Williams DG, Taube D, Vilches AR, Turner DR, Cameron JS, Ogg CS.
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [Abstract] [Full Text] [Related]

  • 3. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E, Choi YJ, Barrios R, Nassar G, Suki WN, Truong LD.
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [Abstract] [Full Text] [Related]

  • 4. Study of lupus nephritis: its classification and the significance of subendothelial deposits.
    Tateno S, Kobayashi Y, Shigematsu H, Hiki Y.
    Q J Med; 1983 Oct; 52(207):311-31. PubMed ID: 6359226
    [Abstract] [Full Text] [Related]

  • 5. Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis?
    Davenport A, Maciver AG, Hall CL, MacKenzie JC.
    Clin Nephrol; 1994 May; 41(5):271-6. PubMed ID: 8050206
    [Abstract] [Full Text] [Related]

  • 6. Class V lupus nephritis: a clinicopathologic study in 152 patients.
    Chen Q, Liu Z, Hu W, Chen H, Zeng C, Li L.
    J Nephrol; 2003 May; 16(1):126-32. PubMed ID: 12653107
    [Abstract] [Full Text] [Related]

  • 7. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L, Pavlović S, Blagojević R, Dimitrijević J, Stojsic T, Ratković M, Kazić K, Lezaić V, Naumović R.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [Abstract] [Full Text] [Related]

  • 8. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases.
    Murphy BF, Fairley KF, Kincaid-Smith PS.
    Clin Nephrol; 1988 Oct; 30(4):175-81. PubMed ID: 3214963
    [Abstract] [Full Text] [Related]

  • 9. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 10. [Membranous glomerulonephritis in children: 20 cases].
    Locard-Bisot S, Cochat P, Gilly J, Parchoux B, Colon S, Rousson A, David L, Larbre F.
    Pediatrie; 1990 Mar; 45(7-8):527-32. PubMed ID: 2170933
    [Abstract] [Full Text] [Related]

  • 11. Long-term survival in idiopathic membranous glomerulonephritis: can the course be clinically predicted?
    Honkanen E, Törnroth T, Grönhagen-Riska C, Sankila R.
    Clin Nephrol; 1994 Mar; 41(3):127-34. PubMed ID: 8187353
    [Abstract] [Full Text] [Related]

  • 12. [Severe nephrotic syndrome with reversible acute kidney failure in lupus-associated membranous nephropathy].
    Pauli-Magnus C, Mettang T, Kuhlmann U.
    Dtsch Med Wochenschr; 1999 Jun 25; 124(25-26):788-92. PubMed ID: 10414228
    [Abstract] [Full Text] [Related]

  • 13. Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse.
    Yumura W, Suganuma S, Nitta K, Sano Y, Uchida K, Nihei H.
    Clin Exp Nephrol; 2004 Dec 25; 8(4):363-8. PubMed ID: 15619038
    [Abstract] [Full Text] [Related]

  • 14. [Membranous glomerulonephritis. Experience at the Instituto Nacional de la Nutrición Salvador Zubirán].
    Correa-Rotter R, Gamba G, Ochoa C, Onuma L, Reyes E, Tamayo JA, Peña JC.
    Rev Invest Clin; 1990 Dec 25; 42(2):114-9. PubMed ID: 2267443
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis.
    do Nascimento AP, Viana Vdos S, Testagrossa Lde A, Leon EP, Borba EF, Barros RT, Bonfá E.
    Arthritis Rheum; 2006 May 25; 54(5):1568-72. PubMed ID: 16645990
    [Abstract] [Full Text] [Related]

  • 16. [Lupus nephritis--clinical and morfological correlation].
    Banković N, Blagojević R, Jovanović D, Sindjić M, Pavlović S, Stojković D, Djukanović Lj.
    Srp Arh Celok Lek; 1994 May 25; 122(7-8):215-7. PubMed ID: 17974390
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug 25; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 18. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
    Ito S, Kuriyama H, Iino N, Iguchi S, Shimada H, Ueno M, Narita I, Nakano M, Nishi S, Karasawa R, Gejyo F.
    Clin Exp Nephrol; 2003 Dec 25; 7(4):290-5. PubMed ID: 14712359
    [Abstract] [Full Text] [Related]

  • 19. Glomerular podocytopathy in patients with systemic lupus erythematosus.
    Kraft SW, Schwartz MM, Korbet SM, Lewis EJ.
    J Am Soc Nephrol; 2005 Jan 25; 16(1):175-9. PubMed ID: 15548564
    [Abstract] [Full Text] [Related]

  • 20. Lupus membranous nephropathy: long-term outcome.
    Pasquali S, Banfi G, Zucchelli A, Moroni G, Ponticelli C, Zucchelli P.
    Clin Nephrol; 1993 Apr 25; 39(4):175-82. PubMed ID: 8491046
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.